A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
about
Advances in Medications and Tailoring Treatment for Alcohol Use DisorderAlcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinenceRecommendations for the Design and Analysis of Treatment Trials for Alcohol Use DisordersAnticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders.GRIK1 genotype and daily expectations of alcohol's positive effects moderate the reduction of heavy drinking by topiramate.Posttreatment effects of topiramate treatment for heavy drinking.Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.Brief Intervention Decreases Drinking Frequency in HIV-Infected, Heavy Drinking Women: Results of a Randomized Controlled Trial.Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care.Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care.Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers.Topiramate in Alcohol Use Disorders: Review and Update.Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs.Anticonvulsant Medication Use in Veterans With Posttraumatic Stress Disorder.New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders.Concurrent Treatment of Substance Use and PTSD.Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder.Pharmacotherapy of alcoholism - an update on approved and off-label medications.A commentary on topiramate treatment of alcohol use disorder in veterans with PTSD: a randomized controlled pilot trial.A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men.Advances in Pharmacotherapy Development: Human Clinical Studies.Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?Systematic Review of Combined Pharmacotherapy for the Treatment of Alcohol Use Disorder in Patients Without Comorbid Conditions.Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.Practical outpatient pharmacotherapy for alcohol use disorder.Effects of LY466195, a selective kainate receptor antagonist, on ethanol preference and drinking in rats.Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trialTopiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)
P2860
Q26799814-5AA51190-67AD-4A36-BE24-EB4F2C907A21Q26801196-405780A7-41D9-495B-A990-1F42F72E902FQ27013929-16BCAB3B-1A26-44A1-94CC-D9939A649FA7Q34472695-CB6867E9-B9AB-43E6-8A2F-182DDBAAB75DQ34609200-61F49338-911F-44A4-B9E6-ACA4C74C5EA6Q34941610-D5BFBA49-D9B0-4ABC-8A86-133C4F6A4CAEQ36231851-EF393DAF-9C13-4B96-9AFA-AB1FA4DB8215Q36250974-A8A263EE-3CD0-4A5E-8086-BA5FAB6CC583Q36837734-D6656F3A-147A-4875-81DD-586BF30CDE10Q37210855-9D46BC02-7151-4A2F-B0F9-38EA0416A70AQ37260470-FA827754-E165-415C-9D87-4512E4C6A3C7Q37384923-2B89CB61-390C-4598-8B15-180C039423D7Q38433702-D0FF1D36-BD7A-4E6D-9D30-B5F09D3BD3B0Q38464015-CD551A48-9FD3-4BEF-9523-4E2CAC0CA59AQ38594528-B60F4400-C113-4E77-A96A-C02E59D667B8Q38750774-3ADAFC18-F7A0-4CC1-BA7B-C6A16F4A9B46Q38843745-6091C747-E86D-4E05-8E7B-1A75C446A8D0Q38859526-B210CFB5-A5BC-42F4-AFE6-733D616FE618Q38916400-89EB6B9D-4A1A-49B2-9807-D734D3AB8094Q39144955-661F4D40-B9AB-44E0-9D57-BF62FE198813Q39409302-57FE0A5E-BA21-48F8-9918-2018A1C4567AQ43061723-B97D7C42-4A76-4F44-ABDF-16A72986BA81Q45328746-F313C18B-8159-4F46-937B-245D41514ABEQ46856315-13CF65C1-3392-40BC-B174-F190260EAD45Q47182010-D95A4EC0-8255-4417-B446-583C9B88F926Q47616924-03E17578-9BEA-414A-9A7D-BE6ED29A781AQ48305886-C78FB3FB-5A0C-4100-9700-2E3957B0AF24Q49605183-A6036710-19BC-475E-88D2-BF214DEC9444Q50101197-0127B7DB-BFFD-44B2-A64B-157B424E2D94Q50317988-42FA85CB-130E-4210-852A-B3271886348DQ50356650-E85234B9-1965-4A62-A9DA-9562CFCFC3F6Q56517489-9E9A1316-ECFE-4575-89AC-9E193D0C16B1Q58773960-C1279B74-ED79-4E17-9061-5296CB96C6EA
P2860
A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
@ast
A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
@en
type
label
A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
@ast
A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
@en
prefLabel
A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
@ast
A meta-analysis of topiramate's effects for individuals with alcohol use disorders.
@en
P2093
P2860
P356
P1476
A meta-analysis of topiramate's effects for individuals with alcohol use disorders
@en
P2093
Janet C Blodgett
John W Finney
Natalya C Maisel
P2860
P304
P356
10.1111/ACER.12411
P577
2014-05-05T00:00:00Z